From: Receptor oligomerization and beyond: a case study in bone morphogenetic proteins
Ligand | Type I receptor (analyte) | Type II receptor (analyte) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | ActR-I | ActR-IB | BMPR-IA | BMPR-IB | ActR-II | ActR-IIB | BMPR-II | ||||||
 | Mean | SD | Mean | Mean | SD | Mean | SD | Mean | SD | Mean | SD | mean | SD |
BMP-2 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
k on × 10-4 [M-1s-1] | NB |  | NB | 3.9 | ± 0.63 | 2.3 | ± 0.56 | NE |  | NE |  | NE |  |
k off × 103 [s-1] | NB |  | NB | 1.9 | ± 0.47 | 8.0 | ± 1.38 | > 100 |  | > 100 |  | > 100 |  |
K D (kin) [nM] | NB |  | NB | 48 | ± 19.6 | 350 | ± 146 | NE |  | NE |  | NE |  |
K D (eq) [nM] | NB |  | NB | NE |  | NE |  | 3800 | ± 608 | 3100 | ± 527 | 13000 | ± 2470 |
GDF-5 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
k on × 10-4 [M-1s-1] | NB |  | NB | 0.5 | ± 0.162 | 0.3 | ± 0.09 | NE |  | NE |  | NE |  |
k off × 103 [s-1] | NB |  | NB | 17 | ± 1.90 | 1.0 | ± 0.124 | > 100 |  | > 100 |  | > 100 |  |
K D (kin) [nM] | NB |  | NB | 3300 | ± 1439 | 300 | ± 123 | NE |  | NE |  | NE |  |
K D (eq) [nM] | NB |  | NB | NE |  | NE |  | 22000 | ± 2420 | 4700 | ± 658 | 60000 | ± 9600 |
BMP-7 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
k on × 10-4 [M-1s-1] | NE |  | NB | 0.3 | ± 0.05 | 3.1 | ± 0.38 | NE |  | NE |  | NE |  |
k off × 103 [s-1] | NE |  | NB | 5.4 | ± 0.70 | 23 | ± 5.84 | > 100 |  | > 100 |  | > 100 |  |
K D (kin) [nM] | NE |  | NB | 1900 | ± 589 | 750 | ± 283 | NE |  | NE |  | NE |  |
K D (eq) [nM] | 58000 | ± 29140 | NB | NE |  | NE |  | 880 | ± 61.6 | 2500 | ± 300 | 9100 | ± 1365 |
Activin-A | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
k on × 10-4 [M-1s-1] | NB |  | NB | NB |  | NB |  | 30 | ± 3.30 | 14 | ± 2.38 | 10 | ± 1.23 |
k off × 103 [s-1] | NB |  | NB | NB |  | NB |  | 44 | ± 10.6 | 9.6 | ± 2.78 | 76 | ± 19.3 |
K D (kin) [nM] | NB |  | NB | NB |  | NB |  | 180 | ± 63.0 | 88 | ± 40.5 | 890 | ± 335 |
K D (eq) [nM] | NB | Â | NB | NB | Â | NB | Â | NE | Â | NE | Â | NE | Â |